Online-Event

Healthtech Innovation Insight: Personalized medication made in Germany: The path to certification as a Class IIb medical device

23. September 2026

15:30 - 16:30

Online-Event

Auf dem Bild ist eine Glühbirne zu sehen, die hell leuchtet insight_iStock©dontree_m_1460400264_ret_blau,

How genetics determines drug efficacy: PGXperts' path to IIb certification and the hurdles of personalized medication.

FHIR is increasingly becoming the common denominator for the exchange of clinical data. The presentation gives an understandable introduction to FHIR against the background of older standards and proprietary interfaces and shows which problem FHIR solves in modern healthcare systems. It also highlights the growing practical importance of FHIR in the context of regulatory developments such as DiGA, European interoperability efforts and EHDS. Using concrete data and API examples, it will become tangible how FHIR is structured, how resources are modeled and what role terminologies such as SNOMED CT and LOINC play for semantic interoperability.

Till Gerken is CTO at Evoleen, a service provider for the development of digital health applications.

Register now!

You can find all other Healthtech Innovation Insights here.

Protected Content

Download only possible after entering PIN.

How do I get a PIN?

Cooperation partner

Specialist contact person

Porträt von Lara Kronester
Lara Kronester
+49 911 20671-242
Innovation network Health, Project manager Digital Health, Bayern Innovativ GmbH, Nuremberg

Organizational contact person

Anna Gschwilm
+49 911 20671-368
Innovation network Health, Project organisation, Bayern Innovativ GmbH, Nuremberg
Tina Schaffer
+49 911 20671-296
Innovation network Health, Project organisation, Bayern Innovativ GmbH, Nuremberg